100
Participants
Start Date
December 11, 2023
Primary Completion Date
December 15, 2024
Study Completion Date
December 30, 2024
MeMed BV® biomarker test
one purple top tube of whole blood (2-3 cc) to be used for the MeMed Key® device processing without the need for centrifuge. The MeMed BV® test takes approximately 15 minutes to process and result. After, the sample has been processed and the MeMed BV® test has resulted, the sample of blood will be discarded for each patient enrolled in the study.
Usual care
Usual care includes diagnostic hematology, chemistry, biomarkers, and culture results along with imaging, consults, and medications, in the treatment of acute viral and/or bacterial illness.
RECRUITING
The University of Texas Health Science Center at Houston, Houston
Collaborators (1)
MeMed Diagnostics Ltd.
INDUSTRY
The University of Texas Health Science Center, Houston
OTHER